EXIT071
PrivateLast Round
Seed
Mar 24, 2025
Total Funding Raised
$2.56M
Company Overview
EXIT071 operates in Healthcare & Life Sciences and is based in Leiden. Its latest recorded funding round was a Seed round in March 2025.
EXIT071 B.V. is a biotechnology company that develops an integrated and automated platform for exosome isolation and molecular analysis for biomarker discovery, diagnostics, and therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EXIT071 Comparables
Compare EXIT071 with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CellBio Scientific | 78% | |
| BioFluidica | 76% | |
| Izon Science | 74% |
For institutional investors. Book with your work email.
EXIT071 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 24, 2025 | ||||
| Grant | Mar 28, 2022 | ||||
| Seed | Feb 15, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
EXIT071 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Libertatis Ergo Holding | Seed |
Recent news
Latest coverage and updates
- receives_awardOct 15, 2026
BioTools Innovator announces that Exit071 wins the Best Video Award at its annual Capstone Event in California on Oct 15th '26.
- recognized_asOct 15, 2026
During BioTools Innovator’s Capstone Event, Exit071 wins the 2026 Best Company Video Award by live audience vote and receives a $10,000 cash prize.
For institutional investors. Book with your work email.
EXIT071 Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EXIT071's valuation, stock price, and market status.
Is EXIT071 a public or private company?
EXIT071 is a private company.
What is the current stock price of EXIT071?
EXIT071 is a private company, so its shares have no public market price. Caplight tracks EXIT071's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EXIT071 worth (valuation)?
Valuation information for EXIT071 is not publicly available.
Can I buy EXIT071 stock?
EXIT071 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EXIT071's last funding round?
EXIT071's most recent funding round was Seed on March 24, 2025.
Who are the main investors in EXIT071?
Key investors in EXIT071 include European Innovation Council Fund, Libertatis Ergo Holding.
Will EXIT071 IPO soon?
No public IPO plans have been announced for EXIT071.
How can I track EXIT071 secondary market activity?
Caplight tracks bids, offers, and trades in EXIT071's shares on secondary markets.